New Postmenopausal Osteoporosis Drug OK'd

April 10, 2019 9:48 AM | Anonymous

April 10, 2019, MedPage Today

WASHINGTON -- The FDA approved romosozumab (Evenity) for osteoporosis in postmenopausal women at high risk for fracture, the agency announced Tuesday

Read more.

Powered by Wild Apricot Membership Software